journal article Jan 06, 2020

Synthesis and antitumor activities of novel bis‐quinazolin‐4(3H)‐ones

Journal of Heterocyclic Chemistry Vol. 57 No. 3 pp. 978-982 · Wiley
View at Publisher Save 10.1002/jhet.3749
Abstract
AbstractWith the aim of obtaining new antitumor agents, a series of bis‐quinazolin‐4(3H)‐ones (3a‐3 f) were designed and synthesized. These products contain 4‐oxo‐1,2,3,4‐tetrahydro‐quinazoline and 3H‐quinazolin‐4‐one moieties linked together via a propyl chain. Cytotoxic activities of 3a‐3 f were evaluated against lung adenocarcinoma (A549), breast carcinoma (MCF‐7) and ovarian cancer (SKOV3) cell lines using MTT method. Cisplatin was used as a positive control. Among the tested compounds 3a, 3b, and 3e showed the best cytotoxic activities against all cancerous cell lines with IC50 values even less than cisplatin. Compounds 3d and 3f also showed desirable cytotoxic activities especially against A549 and MCF‐7.
Topics

No keywords indexed for this article. Browse by subject →

References
28
[2]
El‐Hashash M. Der Pharm Chem (2011)
[4]
Acharyulu P. V. ARKIVOC (2008) 10.3998/ark.5550190.0009.b10
[6]
Al‐Omar M. A. J Saudi Chem Soc (2006)
[7]
[10]
El‐Hashash Maher A. Global J Health Sci (2012)
[13]
ReddyAG BabuVH RaoYJP.A Review on Quinazolines as Anticancer Agents.
[21]
Haghighijoo Z. Trends Pharmacol Sci (2015)
[26]
Fereidoonnezhad M. Appl Organomet Chem (2018)
Cited By
21
Metrics
21
Citations
28
References
Details
Published
Jan 06, 2020
Vol/Issue
57(3)
Pages
978-982
License
View
Funding
Shiraz University of Medical Sciences Award: 93‐01‐05‐7690
Cite This Article
Nasrin Rahmannejadi, Issa Yavari, Soghra Khabnadideh (2020). Synthesis and antitumor activities of novel bis‐quinazolin‐4(3H)‐ones. Journal of Heterocyclic Chemistry, 57(3), 978-982. https://doi.org/10.1002/jhet.3749
Related

You May Also Like